Cell-cycle-related alterations were also identified by earlier molecular and immunohistochemistry-based studies that reported TP53, p21, p27, Ki67, cyclin D1, and D3, among other alterations, and frequently correlated with prognostic features in bladder carcinoma [76,77,78,79]. Here, CCND1 is linked to urinary bladder carcinoma.